MITF or SOX10 have been extensively investigated and allowed a better comprehension of resistance to cancer therapies, underlying the importance of lineage specific signaling in our understanding of how melanoma still overcomes current treatments in the clinic. The gene discussed is MITF; the disease is melanoma.